Document Server@UHasselt >
Research >
Research publications >

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/22824

Title: Response to the letter to the editor 'Reply to "Statistical controversies in clinical research: end points other than survival are vital for regulatory approval of anticancer agents" by H. K. van Halteren'
Authors: Saad, E. D.
Buyse, Marc E.
Issue Date: 2016
Citation: ANNALS OF ONCOLOGY, 27(8), p. 1653-1653
Notes: [Saad, E. D.; Buyse, M.] Int Drug Dev Inst, Louvain La Neuve, Belgium. [Saad, E. D.] Dendrix Res, Sao Paulo, Brazil. [Buyse, M.] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat I BioSt, Diepenbeek, Belgium.
URI: http://hdl.handle.net/1942/22824
DOI: 10.1093/annonc/mdw196
ISI #: 000383182800046
ISSN: 0923-7534
Category: A1
Type: Journal Contribution
Validation: ecoom, 2017
Appears in Collections: Research publications

Files in This Item:

Description SizeFormat
Version in press36.7 kBAdobe PDF

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.